Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For one tablet:

Mukaltin - 0.05 g.

Auxiliary substances (to obtain a tablet weighing 0.3 g) - sodium bicarbonate, tartaric acid, calcium stearate.

Description:Tablets are round, planocylindrical with a risk and facet, from light gray to brownish-gray color with impregnations of a darker and lighter color, with a specific odor.
Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Expectorants
  • Pharmacodynamics:Mukaltin is a mixture of polysaccharides from the herb althea medicinal, possesses expectorant properties. Thanks to reflex stimulation, it intensifies the activity of the ciliated epithelium and the peristalsis of respiratory bronchioles in combination with increased secretion of the bronchial glands.
    Indications:Acute and chronic diseases of the respiratory tract, accompanied by the formation of difficult-to-excrete sputum of increased viscosity (tracheobronchitis, obstructive bronchitis, bronchi-ectazy, pneumonia, etc.) - as part of complex therapy.
    Contraindications:Hypersensitivity to the components of the drug, peptic ulcer of the stomach and duodenum.
    Pregnancy and lactation:The use of the drug during pregnancy and during breastfeeding is possible on the advice of a doctor.
    Dosing and Administration:Inside 1-2 tablets 2-3 times a day before meals. The average course of treatment is 7-14 days. Children can dissolve the pill in 1/3 cup of warm water.
    Side effects:Allergic reactions, rarely - dyspepsia.
    Overdose:Until now, information about an overdose of the drug has not been recorded.
    Interaction:

    Mukaltin can be prescribed concomitantly with other drugs used in the treatment of bronchopulmonary diseases.

    Mucaltin should not be used concomitantly with drugs containing codeine and other antitussive medicines, as this makes it difficult to cough up thinned phlegm.

    Form release / dosage:Tablets of 50 mg.
    Packaging:

    When produced at OJSC "Irbit Chemical Plant"

    30 tablets in cans of orange glass or polymer materials; 10 tablets per contour non-jellied packaging; 10 tablets per contour cell pack. For 100 jars of polymer materials or 900 contour non-jawed packages with an equal number of instructions for use are placed in a cardboard box.

    In the production of "Avexime Siberia"

    10 tablets per contour cell pack.

    For 30 tablets in a jar of polymer materials.

    By 1, 2, 3, 4 or 5 contour cell packs or 1 jar with instructions for medical use are placed in a pack of cardboard.

    Storage conditions:

    In a dry place, at a temperature of 10 to 15 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-001757/09
    Date of registration:10.03.2009 / 24.05.2017
    Expiration Date:Unlimited
    The owner of the registration certificate:AVEKSIMA, JSC AVEKSIMA, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp31.05.2018
    Illustrated instructions
      Instructions
      Up